Point72 Hong Kong Ltd Invests $124,000 in Exponent, Inc. (NASDAQ:EXPO)

Point72 Hong Kong Ltd purchased a new position in shares of Exponent, Inc. (NASDAQ:EXPO) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 1,305 shares of the business services provider’s stock, valued at approximately $124,000.

A number of other large investors have also bought and sold shares of EXPO. GAMMA Investing LLC boosted its stake in Exponent by 67.7% in the second quarter. GAMMA Investing LLC now owns 379 shares of the business services provider’s stock worth $36,000 after purchasing an additional 153 shares in the last quarter. Benjamin F. Edwards & Company Inc. raised its holdings in shares of Exponent by 866.0% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 512 shares of the business services provider’s stock valued at $42,000 after buying an additional 459 shares during the last quarter. Whittier Trust Co. of Nevada Inc. lifted its position in Exponent by 166.5% during the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 517 shares of the business services provider’s stock worth $49,000 after buying an additional 323 shares in the last quarter. Janiczek Wealth Management LLC grew its holdings in Exponent by 293.7% during the 1st quarter. Janiczek Wealth Management LLC now owns 626 shares of the business services provider’s stock worth $52,000 after acquiring an additional 467 shares during the last quarter. Finally, YHB Investment Advisors Inc. acquired a new stake in Exponent in the 1st quarter valued at about $75,000. 92.37% of the stock is currently owned by institutional investors.

Exponent Stock Up 0.6 %

Shares of NASDAQ:EXPO opened at $113.25 on Friday. The firm has a market cap of $5.74 billion, a price-to-earnings ratio of 57.20 and a beta of 0.66. Exponent, Inc. has a 12 month low of $64.61 and a 12 month high of $114.67. The company’s fifty day simple moving average is $106.22 and its 200 day simple moving average is $95.69.

Exponent (NASDAQ:EXPO) last released its earnings results on Thursday, July 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.07. Exponent had a return on equity of 28.39% and a net margin of 19.35%. The business had revenue of $132.43 million for the quarter, compared to analyst estimates of $130.83 million. During the same quarter in the prior year, the company posted $0.50 earnings per share. Exponent’s revenue was up 2.1% on a year-over-year basis. Research analysts expect that Exponent, Inc. will post 2.04 earnings per share for the current fiscal year.

Exponent Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, September 20th. Stockholders of record on Friday, September 6th were issued a $0.28 dividend. The ex-dividend date of this dividend was Friday, September 6th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 0.99%. Exponent’s payout ratio is 56.57%.

Insider Activity at Exponent

In other news, VP John Pye sold 3,956 shares of the firm’s stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $105.00, for a total value of $415,380.00. Following the completion of the sale, the vice president now directly owns 28,422 shares of the company’s stock, valued at $2,984,310. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 2.10% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Separately, Truist Financial reiterated a “buy” rating and set a $120.00 target price (up from $100.00) on shares of Exponent in a research report on Friday, July 26th.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.